This week, the team is joined by Richard Maughan, Senior Director and Head of UK Policy and Public Affairs, Pfizer, to explore how the UK is shaping access to medicine today, and what needs to change in the future. From healthy ageing to the economic cost of respiratory infections, they dive into what the UK is getting right, where it’s falling short and why access to medicine matters now more than ever. A little more on EMJ GOLD’s guest… Richard is Senior Director and Head of UK Policy and Publ...
Jun 24, 2025•22 min•Season 10Ep. 4
This National Blood Week, the team sit down with Anita Gandhi, Vice President, Translational Development, BMS, to explore the last decade of innovation in hematology and what lies ahead for the space. Together, Anita and Jade discuss Anita’s route into the pharmaceutical industry, the current unmet needs of patients with blood cancer, what the future of innovation looks like in hematology and what Anita’s HBA Rising Star Award means to her a decade on. A little more on EMJ GOLD’s guest… Anita is...
Jun 17, 2025•28 min•Season 10Ep. 3
This week on the podcast, the team are joined by omnichannel engagement expert Yacin Marzouki, who shares his strategies on how to make omnichannel work for both pharmaceutical companies and healthcare professionals. Together, Yacin and Jade sit down in the studio to explore what it takes to harmonise omnichannel across an organisation, why content activation is still a major hurdle, how to make sure messaging truly resonates with HCPs and much more. Expect practical insights on operational exce...
Jun 10, 2025•39 min•Season 10Ep. 2
The EMJ GOLD podcast is back for a new season! In the first episode of season 10, the team are joined by Dheepa Chari, Vice President and Head of Global Scientific Communications, GSK, to discuss the past, present and future of scientific communications. Together, Dheepa and Isabel explore her journey from biostatistics to biopharma leadership — and the lessons learned along the way. They discuss what great science communication looks like, where it’s heading next and why storytelling still matt...
Jun 04, 2025•28 min•Season 10Ep. 1
Season 10 is on the horizon, but before we release our first episode, why not tune in to some of Isabel and Jade’s favourite moments from season 9? From leadership insights from top CEOs to navigating setbacks in R&D, there’s plenty to discover in this season’s batch of GOLD Medal Moments. As well as the EMJ GOLD team, you’ll hear from four former guests: Charl van Zyl , CEO, Lundbeck Pharmaceuticals Dr Dennise Broderick , President and Managing Director, Galen Pharma Rebecca Vermeulen , rec...
May 20, 2025•10 min
Join Isabel and Jade as they wrap up Season 9 of the podcast with special guest Dennise Broderick, President and Managing Director, Galen Pharma. In this episode, Jade and Dennise discuss her move from academia to the pharmaceutical industry, her lifelong ambition to be a leader and how she approaches hard decisions in business. A little more on EMJ GOLD’s guest… Dennise is Managing Director and President at Galen – a pharmaceutical company based in Northern Ireland focused on pain management, d...
Apr 08, 2025•30 min•Season 9Ep. 10
How can pharmaceutical companies best navigate setbacks in drug development to deliver breakthroughs in R&D? Find out in this week’s episode, where Isabel and Jade share an interview with Christoph von der Goltz, Global Head of Medicine Central Nervous System and Emerging Areas, Boehringer Ingelheim. Together, he and Jade explore the ins and outs of drug failure, whether to pivot or persevere after an R&D setback, how to better break the stigma of mental illness and much more. A little m...
Apr 01, 2025•22 min•Season 9Ep. 9
Join Isabel and Jade this week as they delve into lessons in leadership and patient centricity with Rebecca Vermeulen, recipient of the Healthcare Businesswomen's Association (HBA) STAR award for 2025. Rebecca shares her journey from pharmacist to industry leader, discussing her approach to leadership, the current landscape for women in pharma and what effective patient centricity looks like in practice. A little more on EMJ GOLD’s guest Rebecca was recently awarded the STAR prize by the Healthc...
Mar 27, 2025•32 min•Season 9Ep. 8
Join Isabel and Jade as they uncover how AI is shaking up the radiology space and beyond with Naiara Martínez Cabrera, Vice President, Global Marketing, DeepHealth. Together, Naiara and Jade explore what first drew the marketing leader to the healthcare sector, why radiology in particular has seen such a boost from artificial intelligence, what other therapy areas can learn from space and much more. A little more on EMJ GOLD’s guest… Naiara Martínez Cabrera is Vice President of Global Marketing,...
Mar 18, 2025•19 min•Season 9Ep. 7
This week, join Isabel and Jade as they explore what’s on the horizon for cardiac care, focusing on the revolutionary impact of remote monitoring with Angelo Auricchio, Chief Medical Officer, Rhythm Management, Boston Scientific. He and Isabel discuss Angelo’s recent career change into the industry, how technology could reform the UK’s NHS, the role of remote monitoring in patient wellbeing and more. A little more on EMJ GOLD’s guest… Angelo Auricchio was appointed Chief Medical Officer, Rhythm ...
Mar 04, 2025•33 min•Season 9Ep. 6
Join Isabel and Jade as they explore the persistent misunderstandings of women’s health in modern medicine with Mary Stutts, CEO of the Healthcare Businesswomen’s Association. In this episode, Mary unpacks the key findings of the HBA’s latest report, which exposes critical gaps in doctors’ understanding of women’s health. She discusses the root causes, the real-world consequences and what the pharmaceutical industry must do to drive meaningful change. A little more on EMJ GOLD’s guest… Mary is t...
Feb 25, 2025•37 min•Season 9Ep. 5
Why do we forget? Join Isabel and Jade as they explore the science behind memory, recall and retention, and uncover why interactive content could be the key to making information stick. In this episode, discover how interactivity enhances learning, helps HCPs recognise the value of new therapies and ultimately improves patient care. Read our article exploring the topic further here . And if you’re interested to see how interactive works in the medical context, check out the interactive article m...
Feb 18, 2025•10 min•Season 9Ep. 4
Join Isabel and Jade for part two of their World Cancer Day special for 2025, where guest Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson, uncovers more of his insights into the oncology space. In this instalment, Martin shares his thoughts on improving access to innovative cancer medicines, improving public trust toward the industry and his personal leadership style. A little more on GOLD’s guest… Martin Price is Vice President for He...
Feb 11, 2025•22 min•Season 9Ep. 3
Join Isabel and Jade as they present a special World Cancer Day 2025 edition of the podcast. They are joined by Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson. In this first instalment of the conversation, Martin and Jade discuss this year’s theme ‘United by Unique’, the increasing importance of real-world evidence in oncology and improving access to innovative cancer medicines. A little more on GOLD’s guest… Martin Price is Vice Pres...
Feb 05, 2025•18 min•Season 9Ep. 2
The EMJ GOLD podcast is back for a new season! In the first episode of Season 9, the team are joined by Charl van Zyl, President and CEO, Lundbeck Pharmaceuticals, to discuss advances in the treatment of neurological disorders, making this the 'decade of the brain', and how industry can do more to support patients living brain conditions. Together, Charl and Isabel explore his career journey in the pharmaceutical industry, Lundbeck’s plans for the future, the role of digital health technology an...
Jan 28, 2025•22 min•Season 9Ep. 1
Curious to discover what might lie ahead for industry in 2025? Join Isabel and Jade in this special episode of the EMJ GOLD podcast as they reflect on whether last year’s predictions for 2024 came true, while three special guests share their predictions and hopes for pharma in the year ahead. The line-up includes Jennifer Schranz of Ipsen, Mercedes Diz of Almirall and EMJ’s own Dr Jonathan Sackier - all of whom share their predictions in their areas of expertise. A little more on GOLD’s guests… ...
Jan 23, 2025•20 min
As 2024 comes to a close, it's time to look back on a year in the pharmaceutical industry. In this final episode of the year, Isabel and Jade are joined by three former guest to reflect on the pivotal moments that defined the past 12 months. They are joined by Jennifer Schranz from Ipsen, Martina Dempsey from Astellas and Elias Revonta, CEO of Orcason, who all return to the podcast to share their insights. Together, they’ll discuss the major trends, challenges and breakthroughs that shaped 2024,...
Dec 24, 2024•24 min
In this final episode of the season, Isabel discusses how to normalise the conversation, not the suffering, around menopause with Dr Cecilia Caetano, Vice President, Head, Global Medical Affairs, Women’s Health, Bayer. Menopause affects over 50% of the world’s population, but its symptoms and effects are often misunderstood or ignored. Find out how industry can help by equipping not only HCPs but also women with the knowledge and awareness to manage menopause on an individual level, debunking th...
Dec 11, 2024•27 min•Season 8Ep. 10
Season 8 is almost over, but before we release our finale episode, why not take a listen to some of our favourite moments from the last couple of months? From an insight into why Gen Z might be turning their sails towards the pharmaceutical industry, to a call for a better understanding of HIV stigma, there’s plenty to discover in this season’s GOLD Medal Moments.
Dec 03, 2024•13 min
In this episode of the EMJ GOLD podcast, Jade and Isabel explore one of the most urgent global health issues: antimicrobial resistance (AMR). As part of World AMR Awareness Week, they are highlighting this year’s theme ‘Educate. Advocate. Act now’. Joining the conversation is Elias Revonta, Founder and CEO, Orcason Medical, who shares his vision for tackling AMR through groundbreaking medical technology. Orcason Medical is pioneering point-of-care devices for ear, nose and throat conditions to a...
Nov 26, 2024•24 min•Season 8Ep. 9
In this episode, Isabel welcomes Patrick Oliver, General Manager for the UK and Ireland at Alfasigma, to explore the company’s exciting entry into the UK market and the evolving landscape of healthcare in the country. In the conversation, Patrick brings his wealth of industry experience to share his vision for Alfasigma’s future, the potential he sees in the UK healthcare market and the unique challenges ahead. They also delve into Lord Darzi’s report on the NHS, examining its implications for h...
Nov 20, 2024•21 min•Season 8Ep. 8
As 2024 draws to a close, what should pharma teams be focusing their budgets on for the final quarter of the year? Join Jade and Isabel as they explore the critical trends that have shaped the industry in 2024. As teams finalise their budgets and plan for the final quarter and year ahead, this conversation brings insights into how strategies like personalised engagement, thought leadership and interactive, on-demand content are making an impact. With real-life examples, learn about the tools you...
Nov 12, 2024•9 min•Season 8Ep. 7
In this new episode, the team welcomes Jennifer Schranz, Senior Vice President, Global Head of Rare Diseases, Ipsen, to investigate the burden faced by women with rare diseases. Together, Jennifer and Jade discuss how the industry can address challenging rare diseases and making a meaningful impact on patients’ lives, the double jeopardy that women with rare diseases face, recent breakthroughs in the space and much more.
Oct 29, 2024•24 min•Season 8Ep. 6
In the latest episode of our podcast, we welcome Richard Lowenthal, CEO, ARS Pharmaceuticals, to explore the company’s mission to address unmet needs in allergy care. During the conversation, Richard shares insights into his early career at the FDA and the regulatory challenges he faced in bringing ARS’s new nasal spray to treat severe allergic reactions to market. He also discusses the future direction of the company and much more. A little more on EMJ GOLD’s guest… Richard Lowenthal is the co-...
Oct 22, 2024•21 min•Season 8Ep. 5
In the latest episode, Jade sits down with Martina Dempsey, Vice President of Commercial Strategy and Operations at Astellas Europe, to discuss empowering women in the pharmaceutical industry. They explore how pharma meets the needs and values of young graduates, the ongoing challenges women face in securing leadership roles, the critical impact of mentorship on career development and much more.
Oct 15, 2024•29 min•Season 8Ep. 4
In this episode, Isabel is joined by Nedim Pipic, Senior Vice President and Global Therapeutic Area Head for Mental Health, Boehringer Ingelheim, to mark World Mental Health Day on 10 October 2024. Their conversation dives into the unique challenges faced by those living with serious mental illnesses, the impact of media representation and the role pharma can play in transforming treatment and quality of life for these patients. Central to their discussion is the importance of amplifying lived e...
Oct 08, 2024•24 min•Season 8Ep. 3
This week, Jean-Bernard Simeon, Senior Vice President and Head, ViiV Healthcare Europe, sits down with the EMJ GOLD team to share his thoughts on the current landscape for patients with HIV in Europe. Together, JB and Jade explore the UNAIDS roadmap to end the HIV epidemic by 2030, the barriers faced by people living with HIV in Europe, stigmas still surrounding the condition and much more.
Oct 02, 2024•28 min•Season 8Ep. 2
The EMJ GOLD podcast is back! In the first episode of season 8, Jade sits down with Chantal Friebertshäuser, Senior Vice President and General Manager, EMEAC, Moderna, to discuss how Europe can combat the recent erosion of trust in vaccines. Together, the two explore the role of governments in addressing vaccine hesitancy, improving vaccine education amongst various groups, how a culture of collaboration can improve the current vaccine landscape and much more.
Sep 24, 2024•26 min•Season 8Ep. 1
The new season of the podcast is only a week away, so before we get started – why not have a listen to some of the best bits from Series 7? From a deep dive into women’s health to why the industry thrives on a little healthy competition, there’s plenty to discover in last season’s highlights. As well as the EMJ GOLD team’s analysis of the key themes, you’ll hear from six former guests: Mercedes Diz , Chief Marketing Office, Almirall Nichole Davies, Global Chief Strategy Officer, VML Health Edmon...
Sep 11, 2024•12 min
In this season finale of the EMJ GOLD podcast, Isabel speaks to Dr Tadaaki Taniguchi, Chief Medical Officer, Head of Medical and Development, Astellas Pharma, about how he strives to challenge the status quo in the pharmaceutical industry. The two discuss how Tadaaki’s time as a surgical oncologist has influenced his leadership style, how collaboration is key for making impacts for patients, the next game changers in cancer treatment and more. A little bit more on EMJ GOLD’s guest… Dr Tadaaki Ta...
Aug 13, 2024•29 min•Season 7Ep. 10
